Farther Finance Advisors
CBIO icon

Farther Finance Advisors’s Crescent Biopharma CBIO Stock Holding History

Farther Finance Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.14K Buy
+215
New +$3.6K ﹤0.01% 5226

Other funds holding CBIO

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's CBIO Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 215 shares worth $3.14K. The stake represents ﹤0.01% of the portfolio and ranks #5226 among its holdings.

5 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Farther Finance Advisors held 215 shares of Crescent Biopharma worth $3.14K as of Q3 2026.
  • Crescent Biopharma was a new Farther Finance Advisors position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5226 holding.
  • 5 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.